Exact Sciences Corp. Company Profile (NASDAQ:EXAS)

About Exact Sciences Corp.

Exact Sciences Corp. logoExact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: EXAS
  • CUSIP: 30063P10
Key Metrics:
  • Previous Close: $18.47
  • 50 Day Moving Average: $17.45
  • 200 Day Moving Average: $10.00
  • 52-Week Range: $4.67 - $22.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.92
  • P/E Growth: -0.47
  • Market Cap: $1.82B
  • Outstanding Shares: 98,332,000
  • Beta: 1.12
Additional Links:
Companies Related to Exact Sciences Corp.:

Analyst Ratings

Consensus Ratings for Exact Sciences Corp. (NASDAQ:EXAS) (?)
Ratings Breakdown: 7 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $16.12 (12.75% downside)

Analysts' Ratings History for Exact Sciences Corp. (NASDAQ:EXAS)
Show:
DateFirmActionRatingPrice TargetDetails
8/15/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$16.00 -> $18.00View Rating Details
8/1/2016Roth CapitalReiterated RatingHold$11.00 -> $15.00View Rating Details
7/31/2016Robert W. BairdReiterated RatingOutperform$18.00View Rating Details
7/31/2016BTIG ResearchReiterated RatingBuy$20.00View Rating Details
7/27/2016Craig HallumBoost Price TargetBuy$18.00 -> $26.00View Rating Details
7/27/2016Jefferies GroupBoost Price TargetBuy -> Buy$13.00 -> $20.00View Rating Details
7/27/2016Benchmark Co.Lower Price TargetHold$14.00 -> $9.00View Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$10.00 -> $15.00View Rating Details
7/26/2016Canaccord GenuityReiterated RatingBuyView Rating Details
7/15/2016William BlairReiterated RatingOutperform$29.00View Rating Details
2/25/2016StephensDowngradeOverweight -> Equal WeightView Rating Details
11/24/2015Lake Street CapitalReiterated RatingHold$12.00 -> $7.00View Rating Details
10/30/2015WedbushLower Price Target$7.00 -> $6.50View Rating Details
5/5/2015JMP SecuritiesBoost Price TargetOutperform$27.00 -> $31.00View Rating Details
10/13/2014Maxim GroupBoost Price TargetSell$8.00 -> $12.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Exact Sciences Corp. (NASDAQ:EXAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/26/2016Q216($0.55)($0.46)$18.54 million$21.20 millionViewListenView Earnings Details
5/3/2016Q116($0.52)($0.49)$15.17 million$14.80 millionViewN/AView Earnings Details
2/24/2016Q415($0.47)($0.41)$14.96 million$14.40 millionViewListenView Earnings Details
10/29/2015Q315($0.44)($0.45)$12.56 million$12.60 millionViewListenView Earnings Details
7/20/2015Q215($0.45)($0.44)$7.96 million$8.10 millionViewListenView Earnings Details
5/4/2015Q115($0.41)($0.40)$4.11 million$4.30 millionViewN/AView Earnings Details
2/24/2015Q414($0.04)($0.38)$19.90 million$1.15 millionViewN/AView Earnings Details
10/27/2014Q314($0.32)($0.39)$0.13 millionViewListenView Earnings Details
7/22/2014Q214($0.25)($0.24)$0.03 millionViewN/AView Earnings Details
5/1/2014Q114($0.19)($0.23)$0.40 million$0.30 millionViewN/AView Earnings Details
2/20/2014Q413($0.19)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details
10/29/2013Q313($0.18)($0.16)$1.02 million$1.00 millionViewN/AView Earnings Details
7/23/2013Q2 2013($0.18)($0.19)$1.02 million$1.00 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.20)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details
2/20/2013Q4 2012($0.18)($0.22)$1.04 million$1.00 millionViewN/AView Earnings Details
10/30/2012Q312($0.21)($0.21)$1.03 million$1.04 millionViewN/AView Earnings Details
7/25/2012($0.20)($0.26)ViewN/AView Earnings Details
5/1/2012($0.18)($0.19)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/3/2011($0.15)($0.15)ViewN/AView Earnings Details
8/2/2011($0.10)($0.13)ViewN/AView Earnings Details
5/3/2011($0.09)($0.08)ViewN/AView Earnings Details
2/15/2011($0.08)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Exact Sciences Corp. (NASDAQ:EXAS)
Current Year EPS Consensus Estimate: $-1.79 EPS
Next Year EPS Consensus Estimate: $-1.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.54)($0.46)($0.51)
Q2 20164($0.56)($0.54)($0.55)
Q3 20164($0.55)($0.47)($0.52)
Q4 20164($0.55)($0.40)($0.50)
Q1 20172($0.44)($0.35)($0.40)
Q2 20172($0.42)($0.34)($0.38)
Q3 20172($0.40)($0.35)($0.38)
Q4 20172($0.38)($0.36)($0.37)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Exact Sciences Corp. (NASDAQ:EXAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Exact Sciences Corp. (NASDAQ:EXAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/3/2016Katherine S ZanottiDirectorBuy3,380$17.93$60,603.40View SEC Filing  
7/26/2016Graham Peter LidgardInsiderSell7,383$14.82$109,416.06View SEC Filing  
7/26/2016Maneesh AroraCOOSell7,359$14.82$109,060.38View SEC Filing  
4/1/2016D Scott CowardSVPSell1,685$6.62$11,154.70View SEC Filing  
3/10/2016D Scott CowardSVPSell2,175$6.05$13,158.75View SEC Filing  
3/10/2016Graham Peter LidgardInsiderSell3,041$6.05$18,398.05View SEC Filing  
3/10/2016Maneesh AroraCOOSell4,042$6.05$24,454.10View SEC Filing  
3/8/2016James Edward DoyleDirectorBuy5,000$6.43$32,150.00View SEC Filing  
3/3/2016Katherine S NapierDirectorBuy3,775$5.38$20,309.50View SEC Filing  
3/1/2016Kevin T ConroyCEOBuy50,000$5.00$250,000.00View SEC Filing  
2/26/2016Kevin T ConroyCEOSell6,895$5.81$40,059.95View SEC Filing  
2/25/2016Graham Peter LidgardInsiderSell2,997$5.52$16,543.44View SEC Filing  
2/25/2016Maneesh AroraCOOSell4,099$5.52$22,626.48View SEC Filing  
2/23/2016Graham Peter LidgardInsiderSell2,411$6.39$15,406.29View SEC Filing  
2/23/2016Kevin T ConroyCEOSell6,866$6.39$43,873.74View SEC Filing  
2/23/2016Maneesh AroraCOOSell2,556$6.39$16,332.84View SEC Filing  
1/11/2016David ThompsonDirectorBuy15,000$6.99$104,850.00View SEC Filing  
2/26/2015Graham Peter LidgardDirectorSell3,938$23.44$92,306.72View SEC Filing  
2/26/2015Kevin T ConroyCEOSell8,425$23.44$197,482.00View SEC Filing  
2/26/2015Maneesh AroraCOOSell3,895$23.44$91,298.80View SEC Filing  
2/24/2015Graham Peter LidgardDirectorSell4,037$22.90$92,447.30View SEC Filing  
2/24/2015Kevin T ConroyCEOSell9,798$22.90$224,374.20View SEC Filing  
2/24/2015Maneesh AroraCOOSell2,995$22.90$68,585.50View SEC Filing  
1/2/2015Graham Peter LidgardInsiderSell3,363$26.72$89,859.36View SEC Filing  
1/2/2015Kevin T ConroyCEOSell9,484$26.72$253,412.48View SEC Filing  
1/2/2015Maneesh AroraCOOSell2,495$26.72$66,666.40View SEC Filing  
10/29/2014Graham Peter LidgardInsiderSell8,015$24.68$197,810.20View SEC Filing  
7/25/2014Graham Peter LidgardVPSell11,081$15.99$177,185.19View SEC Filing  
7/25/2014Kevin T ConroyCEOSell11,336$15.99$181,262.64View SEC Filing  
7/25/2014Maneesh AroraCOOSell9,291$15.99$148,563.09View SEC Filing  
5/5/2014William MeganSVPBuy10,000$11.79$117,900.00View SEC Filing  
2/24/2014Graham Peter LidgardVPSell3,160$14.07$44,461.20View SEC Filing  
2/24/2014Kevin ConroyCEOSell8,708$14.07$122,521.56View SEC Filing  
2/24/2014Maneesh AroraCOOSell2,662$14.07$37,454.34View SEC Filing  
1/2/2014Graham Peter LidgardVPSell10,288$11.96$123,044.48View SEC Filing  
1/2/2014Kevin ConroyCEOSell26,379$11.96$315,492.84View SEC Filing  
1/2/2014Maneesh AroraCOOSell8,627$11.96$103,178.92View SEC Filing  
10/28/2013Graham Peter LidgardVPSell7,430$11.07$82,250.10View SEC Filing  
9/20/2013Sally CrawfordDirectorSell25,000$12.19$304,750.00View SEC Filing  
11/2/2012Kevin T ConroyCEOBuy2,000$9.13$18,260.00View SEC Filing  
11/2/2012Maneesh AroraCFOBuy1,000$9.04$9,040.00View SEC Filing  
11/1/2012Lionel SterlingDirectorBuy5,500$9.08$49,940.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Exact Sciences Corp. (NASDAQ:EXAS)
DateHeadline
4-traders.com logoEXACT Sciences : Elk Creek Partners adds EXACT Sciences Corporation (EXAS) to its portfolio (NASDAQ:EXAS)
www.4-traders.com - August 31 at 4:50 PM
finance.yahoo.com logoExact Sciences to participate in the Baird 2016 Global Healthcare Conference (NASDAQ:EXAS)
finance.yahoo.com - August 30 at 8:01 AM
capitalcube.com logoETF’s with exposure to EXACT Sciences Corp. : August 29, 2016 (NASDAQ:EXAS)
www.capitalcube.com - August 29 at 4:52 PM
zacks.com logoExact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions (NASDAQ:EXAS)
www.zacks.com - August 29 at 9:34 AM
insidermonkey.com logoExact Sciences Corp (EXAS): Billionaire David E. Shaw's D E Shaw Ups Its Stake - Insider Monkey (blog) (NASDAQ:EXAS)
www.insidermonkey.com - August 27 at 4:40 PM
News IconHealthcare Stocks on the Move: EXACT Sciences Corporation ... - Post Registrar (NASDAQ:EXAS)
postregistrar.com - August 23 at 10:02 PM
investopedia.com logoSmaller Biotechs Surging to New Highs (NASDAQ:EXAS)
www.investopedia.com - August 23 at 5:01 PM
realistinvestor.com logoAnalysts Set $15.777 Price Target For EXACT Sciences Corporation (NASDAQ:EXAS) - RealistInvestor.com (NASDAQ:EXAS)
www.realistinvestor.com - August 20 at 4:52 PM
realistinvestor.com logoAnalysts Set $15.777 Price Target For EXACT Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
www.realistinvestor.com - August 19 at 4:52 PM
capitalcube.com logoETF’s with exposure to EXACT Sciences Corp. : August 18, 2016 (NASDAQ:EXAS)
www.capitalcube.com - August 18 at 10:16 PM
streetinsider.com logoExact Sciences (EXAS) Announces Updated CMS Evidence of Coverage for Cologuard - StreetInsider.com (NASDAQ:EXAS)
www.streetinsider.com - August 15 at 12:09 PM
finance.yahoo.com logoCMS Affirms Cologuard® Covered Every Three Years for Medicare Advantage Beneficiaries without Cost Sharing (NASDAQ:EXAS)
finance.yahoo.com - August 15 at 12:09 PM
fool.com logoBetter Buy: Exact Sciences Corporation vs. Myriad Genetics (NASDAQ:EXAS)
www.fool.com - August 15 at 12:09 PM
streetinsider.com logoExact Sciences (EXAS) Announces Expansion of Cologuard Coverage with Florida Blue, HCSC (NASDAQ:EXAS)
www.streetinsider.com - August 11 at 5:05 PM
News IconEXACT Sciences Corporation (NASDAQ:EXAS): We Made 140% Profit In 7 Weeks In 4 Multiple Swing Trades, Join Us (NASDAQ:EXAS)
www.marketnewscall.com - August 11 at 5:05 PM
finance.yahoo.com logoCologuard® Coverage Expands with Updated Policies from HCSC and Florida Blue (NASDAQ:EXAS)
finance.yahoo.com - August 11 at 5:05 PM
finance.yahoo.com logo6:01 am EXACT Sciences announces that Health Care Service Corp. and Florida Blue recently updated their medical policies to cover Cologuard (NASDAQ:EXAS)
finance.yahoo.com - August 11 at 5:05 PM
News IconYahoo! Inc. (NASDAQ:YHOO) & EXACT Sciences Corporation (NASDAQ:EXAS) Stock's Buzzers - Money News (press release) (NASDAQ:EXAS)
www.newsismoney.com - August 9 at 3:38 PM
News IconHC Stocks Review: EXACT Sciences Corporation (NASDAQ:EXAS ... - share market updates (press release) (NASDAQ:EXAS)
sharemarketupdates.com - August 9 at 6:16 AM
streetupdates.com logoHave a look at Analyst Actions: EXACT Sciences Corporation ... - Street Updates (NASDAQ:EXAS)
www.streetupdates.com - August 9 at 6:16 AM
finance.yahoo.com logoEXAS: A Biotech Stock Screening to Prevent Colorectal Cancer (NASDAQ:EXAS)
finance.yahoo.com - August 8 at 10:15 PM
finance.yahoo.com logoExact Sciences to participate in Canaccord Genuity 36th Annual Growth Conference (NASDAQ:EXAS)
finance.yahoo.com - August 8 at 5:02 PM
capitalcube.com logoETF’s with exposure to EXACT Sciences Corp. : August 8, 2016 (NASDAQ:EXAS)
www.capitalcube.com - August 8 at 5:02 PM
News IconDirector of Exact Sciences Corporation (NASDAQ:EXAS), Zanotti Katherine S, buys 3,380 shares worth $60,613 (NASDAQ:EXAS)
empowerednews.net - August 6 at 6:29 AM
tradecalls.org logoThompson Investment Management buys $14371166 stake in EXACT Sciences Corporation (EXAS) - Trade Calls (NASDAQ:EXAS)
www.tradecalls.org - August 5 at 6:37 AM
tradecalls.org logoJefferies Maintains EXACT Sciences Corporation to Buy with Price Target $20.00 - Trade Calls (NASDAQ:EXAS)
www.tradecalls.org - August 3 at 10:37 PM
marketexclusive.com logoThis Hedge Fund Boosts Stake In EXACT Sciences Corporation (NASDAQ:EXAS) - Market Exclusive (NASDAQ:EXAS)
marketexclusive.com - August 3 at 10:37 PM
marketexclusive.com logoThis Hedge Fund Boosts Stake In EXACT Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS)
marketexclusive.com - August 3 at 5:14 PM
streetupdates.com logoAnalyst's Stocks Rating Activity: EXACT Sciences Corporation (NASDAQ:EXAS) , Novo Nordisk A/S (NYSE:NVO) - Street Updates (NASDAQ:EXAS)
www.streetupdates.com - August 3 at 6:12 AM
insidermonkey.com logoExact Sciences Corp (EXAS): D. E. Shaw Boosts Stake In High-Flying Stock - Insider Monkey (blog) (NASDAQ:EXAS)
www.insidermonkey.com - August 2 at 10:33 PM
bizjournals.com logoHumana sues urine analysis company, claiming fraudulent billing (NASDAQ:EXAS)
www.bizjournals.com - August 2 at 5:08 PM
News IconAnalyst Cove rage Update on EXACT Sciences Corporation (NASDAQ:EXAS) - The Voice Registrar (NASDAQ:EXAS)
voiceregistrar.com - August 2 at 9:44 AM
seekingalpha.com logoEXACT Sciences: It Has Happened Again - Seeking Alpha (NASDAQ:EXAS)
seekingalpha.com - August 1 at 4:50 PM
capitalcube.com logoEXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016 (NASDAQ:EXAS)
www.capitalcube.com - August 1 at 4:50 PM
biz.yahoo.com logoEXACT SCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:EXAS)
biz.yahoo.com - August 1 at 4:50 PM
tradecalls.org logoEXACT Sciences Corporation (EXAS) Shares are Up 39.26 ... - Trade Calls (NASDAQ:EXAS)
www.tradecalls.org - August 1 at 9:46 AM
News IconEXACT Sciences Corporation (NASDAQ:EXAS) & Fiat Chrysler Automobiles NV (NYSE:FCAU) Stock's Trend Analysis ... - Money News (press release) (NASDAQ:EXAS)
www.newsismoney.com - August 1 at 9:46 AM
News IconExact Sciences to sell more stock (NASDAQ:EXAS)
host.madison.com - July 31 at 9:19 AM
News IconTraders Recap: Ballard Power Systems Inc. (USA)(NASDAQ:BLDP), EXACT Sciences Corporation(NASDAQ:EXAS) - NYSE Journal (press release) (NASDAQ:EXAS)
stockznews.com - July 30 at 6:36 AM
News IconMizuho Boosts Exact Sciences Corp. (EXAS) Price Target to $15.00 (NASDAQ:EXAS)
lovingfutbol.com - July 29 at 5:00 PM
News IconExact Sciences Corp. (EXAS) PT Raised to $26.00 (NASDAQ:EXAS)
nanonews.org - July 29 at 5:00 PM
biz.yahoo.com logoEXACT SCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of (NASDAQ:EXAS)
biz.yahoo.com - July 29 at 4:21 PM
marketexclusive.com logoWhy EXACT Sciences Corporation (NASDAQ:EXAS) Has Chosen Equity Financing Despite Strong Cash Position (NASDAQ:EXAS)
marketexclusive.com - July 28 at 9:25 PM
News IconGroupon, Inc. (NASDAQ:GRPN) Surpasses Wall Street Expectations- Exact Sciences (NASDAQ:EXAS), Medtronic ... - Seneca Globe (NASDAQ:EXAS)
www.senecaglobe.com - July 28 at 3:40 PM
smarteranalyst.com logoStock Update (NASDAQ:EXAS): EXACT Sciences CorporationA nnounces Agreement to Sell 7000000 Common Shares - Smarter Analyst (NASDAQ:EXAS)
www.smarteranalyst.com - July 28 at 3:40 PM
smarteranalyst.com logoRoth Capital Analyst Weighs in on EXACT Sciences Corporation (EXAS) Following 2Q Results - Smarter Analyst (NASDAQ:EXAS)
www.smarteranalyst.com - July 28 at 3:40 PM
smarteranalyst.com logoBTIG Analyst Has Positive Outlook on EXACT Sciences Corporation (EXAS) Following Earnings - Smarter Analyst (NASDAQ:EXAS)
www.smarteranalyst.com - July 28 at 3:40 PM
thestreet.com logo4 Tech and Biotech Stocks With Momentum to Watch (NASDAQ:EXAS)
www.thestreet.com - July 28 at 12:21 PM
thestreet.com logoExact Sciences (EXAS) Stock Falling After Public Offering (NASDAQ:EXAS)
www.thestreet.com - July 28 at 10:48 AM
News IconEXACT Sciences (NASDAQ:EXAS) & Merck (NYSE:MRK) Stocks on the Move - Money News (press release) (NASDAQ:EXAS)
www.newsismoney.com - July 28 at 7:17 AM

Social

Exact Sciences Corp. (NASDAQ:EXAS) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff